Q-omics provides the consensus-scored SNRPEP3 profile across patient tissues and cancer cell-line models. SNRPEP3 expression is associated with patient survival in 15 of 34 cancer types, with the highest sampling consensus in UCEC. Among the 18 cancer types available for tumor–normal comparison, SNRPEP3 is differentially expressed in 5, with the highest sampling consensus in BRCA. Additionally, SNRPEP3 RNA expression shows 5,056 significant protein co-abundance associations, with the highest sampling consensus in OV. Together, these results highlight UCEC, BRCA, and OV as cancer lineages where SNRPEP3 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.
Premium analyses for SNRPEP3 — synthetic lethality, tumor antigen, and pembrolizumab response.
This table summarizes SNRPEP3 survival associations across molecular data types. SNRPEP3 RNA expression shows survival associations in the most cancer types (15). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.
This table ranks reproducible SNRPEP3 RNA expression–survival associations across cancer types. High SNRPEP3 expression shows unfavorable associations in UCEC and KICH, but favorable associations in LUSC, CESC, MESO and COAD. The UCEC Kaplan–Meier curve shows clear separation, with the high-expression group declining faster, consistent with the unfavorable association (log-rank p = .002). Together, the overview and detailed table identify UCEC as the clearest survival context for SNRPEP3 RNA expression.
This table summarizes SNRPEP3 tumor–normal expression differences by data type. RNA shows broader differences across cancer types, with a lineage consensus of 5. The strongest signals are observed in BRCA for RNA.
This table ranks reproducible tumor–normal expression differences for SNRPEP3. A negative fold-change indicates higher expression in normal tissue than in tumor tissue. SNRPEP3 shows higher tumor expression in BRCA, LUAD, COAD, LIHC and KIRC. The BRCA box plot shows higher SNRPEP3 RNA expression in tumor versus normal tissue (log2 FC = +0.073, t-test p < 0.001).
This table shows molecular features associated with SNRPEP3 in patient tissues and cancer cell lines. In patient samples, SNRPEP3 shows the broadest associations at the RNA and protein expression levels, with OV recurring as the lineage with the largest associated feature set.
